Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors

Therapeutic drug monitoring (TDM) is uncommon in child and adolescent psychiatry, particularly for selective serotonin reuptake inhibitors (SSRIs)—the first-line pharmacologic treatments for depressive and anxiety disorders. However, TDM in children and adolescents offers the opportunity to leverage...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jeffrey R. Strawn, Ethan A. Poweleit, Chakradhara Rao S. Uppugunduri, Laura B. Ramsey
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2021-10-01
Serija:	Frontiers in Pharmacology
Teme:	therapeutic drug monitoring selective serotonin reuptake inhibitor depressive disorder anxiety disorder tolerability pediatric
Online dostop:	https://www.frontiersin.org/articles/10.3389/fphar.2021.749692/full
Oznake:	Označite Brez oznak, prvi označite!